Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique—a prospective, randomized, double-blind study

By Massin N.   Cedrin-Durnerin I.   Coussieu C.   Galey-Fontaine J.   Wolf J.P.   Hugues J.-N.  

Human Reproduction, Vol. 21, Iss. 5, 2006-05 ,pp. : 1204-1211

Oxford University Press

Access to resources Recommend Favorite

Reply: Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique–a prospective, randomized, double-blind study

By Hugues J.N.  

Human Reproduction, Vol. 21, Iss. 11, 2006-11 ,pp. : 3027-3028

Oxford University Press

Access to resources Recommend Favorite

A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon®) in women undergoing ovarian stimulation

By Out HJ  

Human Reproduction, Vol. 14, Iss. 3, 1999-03 ,pp. : 622-627

Oxford University Press

Access to resources Recommend Favorite

The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study

By Tarlatzis B.   Tavmergen E.   Szamatowicz M.   Barash A.   Amit A.   Levitas E.   Shoham Z.  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 90-94

Oxford University Press

Access to resources Recommend Favorite

Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH

By Balasch Juan   Fábregues Francisco   Peñarrubia Joana   Carmona Francisco   Casamitjana Roser   Creus Montserrat   Manau Dolors   Casals Gemma   Vanrell Juan A.  

Human Reproduction, Vol. 21, Iss. 7, 2006-07 ,pp. : 1884-1893

Oxford University Press

Access to resources Recommend Favorite